We thank Carvounis and colleagues for their letter and insightful questions regarding our research.1Intravitreal injection of triamcinolone is emerging as a promising new treatment of diabetic macular edema and age-related retinal degeneration. We agree that it is crucial and urgent to elucidate the possible retinal toxicity of this treatment.
Dierks D, Lei B, Zhang K, Hainsworth DP. Effects of Intravitreous Injection of Preserved and Nonpreserved Triamcinolone in Rabbit Retina—Reply. Arch Ophthalmol. 2006;124(11):1666–1668. doi:10.1001/archopht.124.11.1666-b
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.